FCA Company Profile and Key Details

First Trust China AlphaDEX Fund (NASDAQ:FCA) closed at $27.30 USD, losing -$0.20 (-0.75%) from the previous close of $27.50. The stock is currently mid-range between its 52-week high and low $25.81 and $34.60. With a market capitalization of about $52.52 million, First Trust China AlphaDEX Fund is classified as a micro-cap and shows lower-than-market volatility (beta ~0.71). Key stats such as the average daily volume over the past year has been around 54.11 thousand shares, volume is running light vs its 52-week average. Headquartered in Wheaton, IL, First Trust China AlphaDEX Fund operates in the Financial Services sector and the Asset Management industry. FCA offers broad China exposure with a twistit implements its AlphaDex methodology to select a concentrated portfolio of 50 stocks from the S&P China BMI universe based on a number of growth and value factors, subject to weighting constraints set at 15% above the sector percentages of the base index.

First Trust China AlphaDEX Fund last paid a dividend of 0.79 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.

Short-term trend indicators are bearishly aligned (SMA20 2.73%, SMA50 8.59%, SMA200 21.84%). The stock’s 14-day RSI is 63.45 (firm momentum), while the ATR of 0.62 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -1.26% below its high and over 95.1% above its low. Average 10-day trading volume of 7.23 thousand shares is below the 3-month average of 53.29 thousand, indicating normal recent market interest.

currently trading near 52-week highs band. Our AI forecast model points to short-term weakness (-12.01% over two weeks), a medium-term rise (4.65% over three months), and a longer-term gain (17.22% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that First Trust China AlphaDEX Fund stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -12.01%, with price expected at $24.02 by July 16, 2026, within a range of $23.34 to $24.75 3-Month Outlook: Projected rise of 4.65%, reaching $28.57 by September 30, 2026, with a range of $28.35 to $28.77. 1-Year Outlook: Projected gain of 17.22%, with price at $32.00 by July 02, 2027, within a range of $30.85 to $33.13.